Assistant Professor Dept of Gynecologic Oncology and Reproductive Medicine
Obstetrics & Gynecology
Dr. Shannon N. Westin, MD
|
|
Give Review
Shannon Westin practices Obstetrics & Gynecology. He researched medicine at University of Florida College of Medicine. University of Florida College of Medicine is ranked 43/78 in Research/PrimaryCare. Dr. Shannon N. Westin is a published doctor and has 49 publications published. The lastest was: 'Rational selection of biomarker driven therapies for gynecologic cancers: The more we know, the more we know we don't know.' Shannon Westin accepts all Medicare patients.
Publications
- Role of indocyanine green (ICG) in sentinel node mapping in gynecologic Cancer: Is fluorescence imaging the new standard?
- Management of nodal recurrences of endometrial Cancer with IMRT.
- Uterine adenosarcoma: An analysis on management, outcomes, and risk factors for recurrence.
- Position-related injury is uncommon in robotic gynecologic surgery.
- Significance of lymph node ratio in defining risk category in node-positive early stage Cervical cancer.
- Clinically Significant Endometrial Cancer Risk Following a Diagnosis of Complex Atypical Hyperplasia.
- Overall survival after Pelvic exenteration for gynecologic malignancy.
- Conversion from robotic surgery to laparotomy: A case-control study evaluating risk factors for conversion.
- Minimally invasive surgery for endometrial Cancer: Does operative start time impact surgical and oncologic outcomes?
- The Search Continues: Looking for Predictive Biomarkers for Response to Mammalian Target of Rapamycin Inhibition in Endometrial Cancer.
- A comparison of extraperitoneal versus transperitoneal laparoscopic or robotic para-aortic lymphadenectomy for staging of endometrial Carcinoma.
- Pelvic Exenteration: Impact of age on surgical and oncologic outcomes.
- Successful incorporation of robotic surgery into gynecologic oncology fellowship training.
- Molecular pathogenesis of endometrial Cancers in patients with Lynch syndrome.
- Incidence of trocar site herniation following robotic gynecologic surgery.
- Clinical investigation of receptor and non-receptor tyrosine kinase inhibitors for the treatment of epithelial ovarian Cancer.
- Utility of MLH1 Methylation Analysis in the Clinical Evaluation of Lynch Syndrome in Women with Endometrial Cancer.
- Postoperative outcomes after continent versus incontinent urinary diversion at the time of Pelvic exenteration for gynecologic malignancies.
- Repurposing the Pap smear: one step closer to gynecologic Cancer screening.
- Whole-exome sequencing combined with functional genomics reveals novel candidate driver Cancer genes in endometrial Cancer.
- Investigational agents in development for the treatment of ovarian Cancer.
- The role of mucoregulatory agents after continence-preserving urinary diversion surgery.
- The Effect of Body Mass Index on Surgical Outcomes and Survival Following Pelvic Exenteration.
- Personalized therapy in endometrial Cancer: Challenges and opportunities.
- Modified vertical rectus abdominis myocutaneous flap Vaginal reconstruction: An analysis of surgical outcomes.
- Radical hysterectomy: A comparison of surgical approaches after adoption of robotic surgery in gynecologic oncology.
- Satisfaction with ovarian Carcinoma risk-reduction strategies among women at high risk for breast and ovarian Carcinoma.
- Improved survival in non-Ashkenazi Jewish ovarian Cancer patients with BRCA1 and BRCA2 gene mutations.
- The use of recombinant erythropoietin for the treatment of chemotherapy-induced anemia in patients with ovarian Cancer does not affect progression-free or overall surv...
- Surgical removal of a gigantic abdominal mass: a multidisciplinary approach.
- The use of recombinant erythropoietin for the treatment of chemotherapy-induced anemia in patients with ovarian Cancer does not effect progression-free or overall surv...
- Early Cervical neoplasia: advances in screening and treatment modalities.
- Molecular clustering of endometrial Carcinoma based on estrogen-induced gene expression.
- Perception of screening and risk reduction surgeries in patients tested for a BRCA deleterious mutation.
- Enhanced estrogen-induced proliferation in obese rat endometrium.
- Carcinoma of the lower uterine segment: a newly described association with Lynch syndrome.
- What women with ovarian Cancer think and know about genetic testing.
- Social factors affecting treatment of Cervical cancer: ethical issues and policy implications.
- STK15 F31I polymorphism is associated with increased uterine Cancer risk: a pilot study.
- Incidence of symptomatic deep venous thrombosis with epoetin alfa or darbepoetin alfa treatment of anemia in patients with ovarian or primary peritoneal Cancer.
- Targeted therapy by combined inhibition of the RAF and mTOR kinases in malignant spindle cell neoplasm harboring the KIAA1549-BRAF fusion protein.
- Genetic polymorphisms and endometrial Cancer risk.
- The obstetric forceps: shrouded in mystery.
- Optimization of MR Imaging for Pretreatment Evaluation of Patients with Endometrial and Cervical Cancer.
- FBXW7 Mutations in Patients with Advanced Cancers: Clinical and Molecular Characteristics and Outcomes with mTOR Inhibitors.
- MET nucleotide variations and amplification in advanced ovarian Cancer: characteristics and outcomes with c-Met inhibitors.
- Rational selection of biomarker driven therapies for gynecologic Cancers: The more we know, the more we know we don't know.
- Survivors of gynecologic malignancies: impact of treatment on health and well-being.
Procedures Preformed
- Colpopexy
- Colposcopy
- EndoCervical Curettage
- Gynecologic Cancer Screening
- View All
Conditions Treated
- Atrophic Vaginitis
- Carcinoma in Situ
- Cervical Cancer
- Cervical Polyps
- View All
Doctors Specialties
- Obstetrics
- Gynecology
Accepted Insurances
- Amerigroup (Wellpoint)
- Blue Card PPO
- Blue Choice
- CHAMPVA
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- LocalPlus
- Open Access Plus
- Commercial Insurance Company
- First Health (Coventry Health Care) PPO
- Choice Care PPO
- Mail Handlers Benefit Plan (MHBP)
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Old Surety Life Insurance CompanyMedicare MCR
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Education
-
University of Florida College of Medicine
Hospital
-
University of Texas M.D. Anderson Cancer Center
Drug Facts
| NPI NUMBER | 1740454008 | |
| NPPES Provider LastName | WESTIN | |
| NPPES Provider FirstName | SHANNON | |
| NPPES Provider ZIPCode | 770304009 | |
| NPPES Provider State | TX | |
| Specialty Description | Obstetrics/Gynecology | |
| Total Claim Count | 179.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 15.0 | |
| Percent Opioid Claims | 8.38 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1740454008 |
| Last Name Of The Provider | WESTIN |
| First Name Of The Provider | SHANNON |
| View All |
Similar Doctors
|
|
Dr. Robert C. Maier, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Geoffrey A. Zimmerman, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. June W. Colman, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Marcelo Totorica, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tessa A. Kincade, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Earl J. Lombard, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Charis A. Venditti, MD
This Doctor is OpenDoctor Recommended.
|